Accuray reported $4.71M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Trinity Biotech USD -1.3M 796K Dec/2025